drugset / Trial / NCT06138041

Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy

NCT06138041 ↗

Not yet recruiting 770 enrolled Sichuan Cancer Hospital and Research Institute
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The goal of this double-center, double-blind, randomized controlled clinical trial is to compare the effect of intravenous lidocaine infusion on postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. The main question it aims to answer are whether intravenous lidocaine reduce postoperative pulmonary complications in patients undergoing minimally invasive esophagectomy. Participants will be given intravenous lidocaine infusion in lidocaine group or placebo in control group.

Timeline

Start
2025-02-01
Primary completion
2025-06-30
Completion
2025-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous

Indications